Skip to main content

Year: 2025

Suvic re-organizes its Executive Management team

Dovre Group Plc        Press release        March 12, 2025, at 9:45 am Suvic re-organizes its Executive Management team After reporting extensive losses from two projects in Sweden, Suvic Oy has decided to make changes in the Executive Management of the company. The company will initiate the search for a new CEO immediately. The current CEO Ville Vesanen continues in the position until a replacement has been hired. He will then assume the role of COO (Chief Operating Officer). Suvic’s CFO Ville Kemppinen will also step down and the search for a new CFO will be initiated. He remains committed to carrying out the CFO duties until a controlled handover to his replacement has been completed. Ilari Koskelo, Vice Chairman of Dovre’s Board of Directors, joins Suvic’s management team to support the operational and financial performance of Suvic...

Continue reading

Negative profit warning: Dovre Group Plc lowers its guidance for 2024

Dovre Group Plc        Inside information        March 12, 2025, at 9:37 am Negative profit warning: Dovre Group Plc lowers its guidance for 2024 On February 3, 2025, Dovre Group updated its guidance for 2024 as: Dovre Group’s revenue is expected to be approximately 99 MEUR and the operating profit (EBIT) is expected to be approximately -12 MEUR. New guidance for 2024: Dovre Group’s revenue is expected to be approximately 99 MEUR and the operating profit (EBIT) is expected to be approximately -22 MEUR. The lowered guidance is due to two wind farm projects started by Suvic in Sweden during 2024 that have overrun their cost budgets considerably. Based on the information reported by Suvic’s management, the estimated total losses of the two projects upon completion are EUR 8,7 million and EUR 10 million. The losses are fully booked in the...

Continue reading

Wendel announces the successful placement of Bureau Veritas shares as part of a prepaid 3-year forward sale representing approximately 6.7% of Bureau Veritas share capital

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW Wendel announces the successful placement of Bureau Veritas shares as part of a prepaid 3-year forward sale representing approximately 6.7% of Bureau Veritas share capital and increases its financial flexibility by reducing the pro forma1 loan-to-value ratio to approximately 17% Wendel today announces the successful placement of 30,357,140 shares of Bureau Veritas (representing approximately 6.7% of Bureau Veritas’ share capital2) at a price of €27.25 per share (the “Offering Price”). As indicated in the press release published yesterday, Wendel entered into a prepaid 3-year forward sale agreement with BNP Paribas...

Continue reading

Wolters Kluwer releases 2024 Annual Report

PRESS RELEASE Wolters Kluwer releases 2024 Annual Report Alphen aan den Rijn — March 12, 2025 — Wolters Kluwer, a global leader in professional information solutions, software, and services, today published its 2024 Annual Report. The 2024 annual report is available as an ESEF (European Single Electronic Format) file and as a PDF file on the Wolters Kluwer website, www.wolterskluwer.com. The report includes the company’s sustainability statements prepared in accordance with European Sustainability Reporting Standards (ESRS) the mandatory framework set by the EU Corporate Sustainability Reporting Directive (CSRD), and provides an overview of the company’s expert solutions strategy. Highlights of the 2024 sustainability statements include the results of our double materiality assessment and expanded disclosures. We discuss progress against...

Continue reading

The Agfa-Gevaert Group in 2024: strong performance from growth engines offsets decline in traditional film markets – regulated information

                                                                              Regulated information March 12, 2025 – 7:45 a.m. CET        The Agfa-Gevaert Group in 2024: strong performance from growth engines offsets decline in traditional film markets The Agfa-Gevaert Group posted strong Q4 revenue growth, profitability and free cash flow, with record performances of its growth engines. The strong year-end resulted in significant full year revenue growth and a strong profitability step up in Digital Printing Solutions, Green Hydrogen Solutions and Direct Radiography, as well as a significant increase in order intake in HealthCare IT, with a high share of cloud-based and net new customer contracts. This was counterbalanced by an accelerated market decline for the traditional film activities. The savings program to align the costs...

Continue reading

Crédit Agricole Assurances has successfully placed its first issue of 750,000,000 euros of perpetual super subordinated “Restricted Tier 1” notes

Press release                                                                                                      Paris, March 12, 2025This press release may not be distributed or published directly or indirectly in the United States, Canada, Australia or Japan.Crédit Agricole Assurances has successfully placed its first issue of 750,000,000 euros of perpetual super subordinated “Restricted Tier 1” notes with an initial fixed annual interest rate of 6.250%1.          Crédit Agricole Assurances announces today that it has completed the placement of its first issue of a perpetual super subordinated “Restricted Tier 1” notes (the “Notes”) in Euro, with an initial fixed interest rate of 6.250%1 resetting in 2035, for a nominal amount of 750,000,000 euros (the “Issue”). This transaction is part of Crédit Agricole Assurances’ active capital...

Continue reading

Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins

PARIS, FRANCE, March 12th, 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven company, announced today the appointment of Olivia Brown as, EVP, Global Head of Neurotoxins, effective April 1st, 2025.  She will serve on Ipsen’s Executive Leadership Team (ELT) and report directly to Chief Executive Officer David Loew. In this newly created role, she will lead Ipsen’s global neurotoxins franchise, overseeing strategy and execution across both therapeutic and aesthetic indications. Over the last 30 years in the neurotoxins market, Ipsen has established itself as one of the leading players in neurosciences, successfully driving research, clinical development and growth based on significant manufacturing know-how and capacity. “We are delighted to welcome Olivia to Ipsen’s Executive Leadership Team. With her...

Continue reading

EHang Reports Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

Record-high quarterly and annual revenues, up 190.2% and 288.5% YoY, respectively Record-high quarterly and annual delivery volume, 216 units in 2024 1st year and 3rd consecutive quarter of non-GAAP profitability1 1st year and 5th consecutive quarter of positive operating cash flow Fiscal year 2025 revenues expected to be around RMB900 million, up 97% YoYGUANGZHOU, China, March 11, 2025 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading Urban Air Mobility (“UAM”) technology platform company, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Operational and Financial Highlights for the Fourth Quarter of 2024EH216 series eVTOL2 sales and deliveries achieved a record-high of 78 units, representing a 239.1% increase...

Continue reading

Tecan reports 2024 financial results, enhancing operational resilience amid challenging conditions

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan reports 2024 financial results, enhancing operational resilience amid challenging conditions Financial results for the full year 2024 – HighlightsSales of CHF 934.3 million (2023: CHF 1,074.4 million), down by -13.0% in Swiss francs and by -11.5% in local currencies; H2 sales decrease by -11.3% in local currencies Decline in sales mainly due to softness in the instrument business with biopharmaceutical companies globally and general market weakness in China Adjusted EBITDA of CHF 164.4 million (2023: CHF 220.6 million), adjusted EBITDA margin reached 17.6% (2023: 20.5%) Margins declined due to lower sales volume, but were partly offset by cost-reduction measures Adjusted net profit of CHF 103.1 million (2023: CHF 164.4 million), adjusted earnings...

Continue reading

Lantronix to Showcase Embedded Compute, Industrial IoT and Out-of-Band Solutions at Embedded Tech India Expo

IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling Edge Intelligence, today announced that it will showcase its leading-edge embedded compute, Industrial IoT (IIoT) and out-of-band management solutions at Embedded Tech India Expo, co-located with Convergence India Expo, being held March 19–21, 2025, in Bharat Mandapam, New Delhi, India. Lantronix will display at booth #C248 in Hall 3 (Embedded Compute section). “Our presence at the Embedded Tech India Expo reinforces our dedication to delivering cutting-edge solutions that support India’s evolving technology landscape and its rapidly growing sectors in Smart Cities, Enterprise and Transportation,” said Mathi Gurusamy, chief strategy officer at Lantronix. “A global technology...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.